The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C

This publication has 36 references indexed in Scilit:

• Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
  JAMA Network Open, 2021
• Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children
  JAMA, 2021
• American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
  Arthritis & Rheumatology, 2021
• Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management
  The Journal of Pediatrics, 2021
• A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process
  The Lancet Child & Adolescent Health, 2021
• COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis
  Journal of Allergy and Clinical Immunology, 2021
• Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
  JAMA, 2020
• Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
  JAMA, 2020
• Hyperinflammatory shock in children during COVID-19 pandemic
  The Lancet, 2020
• Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records
  European Journal of Pediatrics, 2017